Search - tctmd.com

Displaying 881 - 900 of 1859

Sort: Relevancy | Date

Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions

News Daily News

Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions

December 01, 2017

iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI

News Daily News

iFR May Help Rule Out Significant Nonculprit Lesions After Primary PCI

November 30, 2017

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

News Conference News AHA 2017

Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear

November 14, 2017

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

News Conference News AHA 2017

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

November 12, 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

News Conference News AHA 2017

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

November 11, 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

November 02, 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

24-Months Outcomes of PACUS Trial: Randomized Clinical Trial to Compare Ultrasound Enhanced Delivery of Paclitaxel and DEB in Patients With Critical Limb Ischemia and Femoral/Popliteal Disease

Presentation TCT 2017

24-Months Outcomes of PACUS Trial: Randomized Clinical Trial to Compare Ultrasound Enhanced Delivery of Paclitaxel and DEB in Patients With Critical Limb Ischemia and Femoral/Popliteal Disease

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Costantino Del Giudice

November 01, 2017

$My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!$

Presentation TCT 2017

My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!

Presenter: Timothy D. Henry, Marc S. Penn

October 31, 2017

Critical Limb Ischemia Update, and the STOP-PAD Trial

Presentation TCT 2017

Critical Limb Ischemia Update, and the STOP-PAD Trial

Presenter: Timothy D. Henry, Marc S. Penn, Mehdi H. Shishehbor

October 31, 2017

Can Functional Testing for Ischemia and Viability Guide Revascularization in Heart Failure?

Presentation TCT 2017

Can Functional Testing for Ischemia and Viability Guide Revascularization in Heart Failure?

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, James E. Udelson

October 31, 2017

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Staged Revascularization After Ischemia Testing Is the Preferred Strategy!

Presentation TCT 2017

Multivessel PCI Debate: Based on What We Know Today - Culprit Lesion Only PCI With Staged Revascularization After Ischemia Testing Is the Preferred Strategy!

Presenter: Stefan K. James, Ran Kornowski, Thomas Engstroem

October 31, 2017

TCT 69: Comparison of Quantitative Flow Ratio and Fractional Flow Reserve to Identify Myocardial Ischemia: Validation With Myocardial Perfusion Scintigraphy and Cardiovascular Magnetic Resonance

Presentation TCT 2017

TCT 69: Comparison of Quantitative Flow Ratio and Fractional Flow Reserve to Identify Myocardial Ischemia: Validation With Myocardial Perfusion Scintigraphy and Cardiovascular Magnetic Resonance

Presenter: Nick Curzen, William F. Fearon, Jelmer Westra

October 31, 2017

TCT 62: Thirty-Day Readmissions After Endovascular or Surgical Revascularization for Chronic Mesenteric Ischemia: Insights From the National Readmissions Database

Presentation TCT 2017

TCT 62: Thirty-Day Readmissions After Endovascular or Surgical Revascularization for Chronic Mesenteric Ischemia: Insights From the National Readmissions Database

Presenter: Mark C. Bates, Dharam J. Kumbhani, Fabio Lima, MD

October 31, 2017

Surgical vs Endovascular Treatment and Outcomes: Appropriate Use Considerations

Presentation TCT 2017

Surgical vs Endovascular Treatment and Outcomes: Appropriate Use Considerations

Presenter: D. Christopher Metzger, Ido Weinberg, Peter A. Schneider

October 31, 2017

REVASCTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

News Conference News TCT 2017

REVASC: CTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

October 31, 2017

Long-term Absorb BVS Data Continue to Disappoint

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.